US Broker Ratings

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Uncovering a 19.81% Upside Potential

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a notable player in the healthcare sector, specifically within the drug manufacturing industry, is attracting significant attention from investors due to its promising growth prospects...

MiMedx Group, Inc (MDXG) Stock Analysis: A 79.94% Potential Upside in the Biotechnology Sector

MiMedx Group, Inc. (NASDAQ: MDXG), a promising entity within the healthcare sector, particularly the biotechnology industry, has caught the attention of investors with its significant growth potential. With a market..

agilon health, inc. (AGL) Stock Analysis: Navigating a Challenging Healthcare Landscape with a 57% Upside Potential

agilon health, inc. (NYSE: AGL), a key player in the healthcare sector, is navigating a complex landscape filled with both challenges and opportunities. With a market capitalization of $265.83 million,..

Pulse Biosciences, Inc (PLSE) Stock Analysis: Exploring a 68% Potential Upside in the Healthcare Sector

Pulse Biosciences, Inc. (NASDAQ: PLSE), a pioneering company in the realm of bioelectric medicine, stands at a crucial intersection of innovation and market potential. Headquartered in Miami, Florida, Pulse Biosciences..

Adaptive Biotechnologies (ADPT) Stock Analysis: Unveiling Growth Potential Amid a Robust Healthcare Sector

Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a prominent player in the biotechnology industry, has garnered significant investor attention due to its innovative approach in the healthcare sector. Headquartered in Seattle, Washington,..

Indivior PLC (INDV) Investor Outlook: Buy Ratings and 11.32% Potential Upside Highlight Growth Opportunities

Indivior PLC (INDV) stands as a significant player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. Its market capitalization of $4.12 billion reflects its stature..

Opko Health, Inc. (OPK) Stock Analysis: Unpacking a 173.72% Potential Upside Amid Challenging Financials

Opko Health, Inc. (NASDAQ: OPK), a player in the healthcare sector with a focus on diagnostics and pharmaceuticals, presents a compelling case for investors looking at both its potential and..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Exploring a 15.59% Potential Upside Amid Growth Prospects

Healthcare Services Group, Inc. (NASDAQ: HCSG), a significant player in the healthcare support services sector, stands out not only for its robust market presence but also for its promising investment..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: A Biotech Powerhouse with a 16.49% Upside Potential

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) is making waves in the biotechnology sector with its focus on addressing diseases driven by dysregulated aldosterone. With a market capitalization of $3.37 billion, this..

Kestra Medical Technologies, Ltd (KMTS) Stock Analysis: A High-Growth Opportunity in Healthcare Innovation

Kestra Medical Technologies, Ltd (KMTS), a promising player in the healthcare sector, has been gaining traction among investors due to its innovative approach in the medical instruments and supplies industry...

Ligand Pharmaceuticals (LGND) Stock Analysis: Unpacking a 14.8% Potential Upside in the Biotech Sector

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) is emerging as a compelling player in the biotechnology sector, with a promising 14.8% potential upside according to recent analyst ratings. With a market capitalization..

Arrowhead Pharmaceuticals (ARWR) Stock Analysis: Explosive Growth Potential with 24.64% Upside

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR), a prominent player in the biotechnology sector, is catching the attention of investors with its innovative approach to tackling intractable diseases. With a current market..

Organon & Co. (OGN) Stock Analysis: Navigating a 36.92% Potential Upside Amid Market Challenges

In the dynamic landscape of the healthcare sector, Organon & Co. (NYSE: OGN) stands as a distinctive player, focusing on prescription therapies and medical devices with a strong emphasis on..

Kiniksa Pharmaceuticals, Ltd. (KNSA) Stock Analysis: A Promising 28.66% Upside Potential

Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) has been making waves in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization of $3.18 billion, this..

NeoGenomics, Inc. (NEO) Stock Analysis: Exploring 13.41% Potential Upside in the Healthcare Diagnostics Arena

For investors seeking opportunities within the healthcare sector, NeoGenomics, Inc. (NASDAQ: NEO) presents an intriguing proposition. As a prominent player in the diagnostics and research industry, NeoGenomics operates a network..

Neogen Corporation (NEOG) Investor Outlook: Potential Upside of 39.36% Amidst Healthcare Sector Challenges

Neogen Corporation (NEOG), a notable player in the healthcare sector within the diagnostics and research industry, presents an intriguing case for investors seeking a blend of growth potential and sector..

Guardian Pharmacy Services, Inc (GRDN): Growth Potential with 18.55% Upside

Guardian Pharmacy Services, Inc. (GRDN), a prominent player in the healthcare sector, operates within the medical care facilities industry, focusing on providing specialized pharmacy services to long-term care facilities (LTCFs)..

Progyny, Inc. (PGNY) Stock Analysis: Unveiling a 10.56% Potential Upside in the Healthcare Plans Sector

Progyny, Inc. (NASDAQ: PGNY) stands as a unique player in the healthcare sector, specifically within the niche of fertility and family-building benefits management. With a market capitalization of $2.27 billion,..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Exploring Growth Potential and Analyst Ratings

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) has been garnering attention in the biotechnology sector for its focus on addressing unmet medical needs in autoimmune diseases. As a company headquartered in Edmonton,..

Harmony Biosciences Holdings, Inc. (HRMY): A Promising Biotech with a 29% Potential Upside

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) has emerged as a notable player in the biotechnology sector, particularly focusing on therapies for rare and neurological diseases. With a market capitalization of..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds